-
Oct 21, 2024 | 
ard.bmj.com | Laure Gossec |Laura Coates |Dafna D Gladman |Jacob A Aelion
Treatment of early oligoarticular psoriatic arthritis with apremilast: primary outcomes at week 16 from the FOREMOST randomised controlled trial Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
-
Aug 20, 2024 | 
ard.bmj.com | Laure Gossec |Laura Coates |Dafna D Gladman |Jacob A Aelion
DiscussionClinical trial data to support treatment guidelines for oligoarticular PsA are currently limited. FOREMOST is, to our knowledge, the first large, randomised, placebo-controlled trial only enrolling patients with oligoarticular PsA and provides valuable information on how patients with early disease and limited joint involvement respond to apremilast treatment.
-
Aug 2, 2024 | 
acrjournals.onlinelibrary.wiley.com | Arthur Kavanaugh |Philip Mease |Laure Gossec
INTRODUCTION Psoriatic arthritis (PsA) is a heterogeneous condition associated with a high disease burden and significant comorbidities.1 The primary treatment goal in PsA is to maximize health-related quality of life (QoL) by achieving the lowest possible level of disease activity, managing symptoms, and preventing irreversible joint damage and disability.1, 2 Disease activity and its control in PsA can be assessed using a variety of measures, including minimal disease activity (MDA) and...
-
Aug 2, 2024 | 
acrjournals.onlinelibrary.wiley.com | Laure Gossec |Louis Bessette |Ricardo M. Xavier
Supporting Information Filename Description acr25408-sup-0001-Disclosureform.pdfPDF document, 551 KB Disclosure Form acr25408-sup-0002-Supinfo.docxWord 2007 document , 311.1 KB Supporting Information
-
Apr 11, 2024 | 
healio.com | Justin Cooper |Shenaz Bagha |Laure Gossec
You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Key takeaways: EULAR recommendations on pharmacological PsA management cover all available drugs in a “practical and progressive approach.” Recommendations should aid clinicians and advocacy for improved access.
-
Mar 27, 2024 | 
acrjournals.onlinelibrary.wiley.com | Vibeke Strand |Laure Gossec |Laura Coates
Supporting Information Filename Description acr25333-sup-0001-Disclosureform.pdfPDF document, 1.5 MB Disclosure Form acr25333-sup-0002-TableS1.docxWord 2007 document , 34.1 KB Supplemental Table S1. Spearman correlations at baseline and at Week 16 between PsAID-12 scores and comparative health outcomes.
-
Mar 18, 2024 | 
ard.bmj.com | Laure Gossec |Andreas Kerschbaumer |Daniel Aletaha |Xenofon Baraliakos
Of the seven OAPs, three remain unchanged, three were reworded and one has been added (overarching principle G). For more information on the thought process leading to the OAPs (unchanged or slightly changed), please refer to the 2015 and 2019 recommendations manuscripts.9 15 Key points from the discussion of the OAPs are addressed in the following:A. Psoriatic arthritis is a heterogeneous and potentially severe disease, which may require multidisciplinary treatment (unchanged).
-
Jul 13, 2023 | 
ard.bmj.com | Johannes Jacobs |Laure Gossec |Mwidimi Ndosi |Pedro Machado
http://orcid.org/0000-0002-2517-0247Ricardo J O Ferreira1,2, Paco M J Welsing3, http://orcid.org/0000-0002-7438-3468Johannes WG Jacobs4, http://orcid.org/0000-0002-4528-310XLaure Gossec5,6, http://orcid.org/0000-0002-7764-3173Mwidimi Ndosi7, http://orcid.org/0000-0002-8411-7972Pedro M Machado8,9, http://orcid.org/0000-0002-5781-158XDésirée van der Heijde10, http://orcid.org/0000-0002-2782-6780Jose AP Da Silva1,11 1 Rheumatology Department, Centro Hospitalar e Universitário de Coimbra EPE,...
-
Apr 12, 2023 | 
ard.bmj.com | Pedro Machado |Martin Schäfer |Anja Strangfeld |Laure Gossec
http://orcid.org/0000-0002-8411-7972Pedro M Machado1,2,3, Martin Schäfer4, http://orcid.org/0000-0002-6233-022XAnja Strangfeld4, http://orcid.org/0000-0002-4528-310XLaure Gossec5,6, Milena Gianfrancesco7, Saskia Lawson-Tovey8,9, Elsa F Mateus10,11, http://orcid.org/0000-0002-4401-2551Loreto Carmona12, http://orcid.org/0000-0001-8242-9262Kimme L Hyrich8,9, http://orcid.org/0000-0002-3156-3418Philip C Robinson13,14, Jinoos Yazdany7 1 Centre for Rheumatology and Department of Neuromuscular...
